C. Alix-panabieres, H. Schwarzenbach, and K. Pantel, Circulating tumor cells and circulating tumor DNA, Annu Rev Med, vol.63, pp.199-215, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01872958

K. Pantel and C. Alix-panabieres, Real-time liquid biopsy in cancer patients: fact or fiction?, Cancer research, vol.73, pp.6384-6388, 2013.

F. C. Bidard, Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data, Lancet Oncol, vol.15, issue.14, pp.70069-70074, 2014.

S. J. Cohen, Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer, Journal of clinical oncology: official journal of the American Society of Clinical Oncology, vol.26, pp.3213-3221, 2008.

M. Cristofanilli, Circulating tumor cells, disease progression, and survival in metastatic breast cancer, The New England journal of medicine, vol.351, pp.781-791, 2004.

J. S. De-bono, Phase I pharmacokinetic and pharmacodynamic study of LAQ824, a hydroxamate histone deacetylase inhibitor with a heat shock protein-90 inhibitory profile, in patients with advanced solid tumors, Clinical cancer research: an official journal of the American Association for Cancer Research, vol.14, pp.6663-6673, 2008.

L. Zhang, Meta-analysis of the prognostic value of circulating tumor cells in breast cancer, Clinical cancer research: an official journal of the American Association for Cancer Research, vol.18, pp.5701-5710, 2012.

L. Zhang, The identification and characterization of breast cancer CTCs competent for brain metastasis, Science translational medicine, vol.5, 2013.

M. Yu, S. Stott, M. Toner, S. Maheswaran, and D. A. Haber, Circulating tumor cells: approaches to isolation and characterization, The Journal of cell biology, vol.192, pp.373-382, 2011.

D. Gao, Organoid cultures derived from patients with advanced prostate cancer, Cell, vol.159, pp.176-187, 2014.

Z. Zhang, Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model, Oncotarget, vol.5, pp.12383-12397, 2014.

A. Kulasinghe, Short term ex-vivo expansion of circulating head and neck tumour cells, Oncotarget, vol.7, pp.60101-60109, 2016.

L. Cayrefourcq, Establishment and characterization of a cell line from human circulating colon cancer cells, Cancer research, vol.75, pp.892-901, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01990012

C. Alix-panabieres, Molecular Portrait of Metastasis-Competent Circulating Tumor Cells in Colon Cancer Reveals the Crucial Role of Genes Regulating Energy Metabolism and DNA Repair, Clinical chemistry, vol.63, pp.700-713, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01793403

M. Todaro, CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis, Cell stem cell, vol.14, pp.342-356, 2014.

A. Muller, Involvement of chemokine receptors in breast cancer metastasis, Nature, vol.410, pp.50-56, 2001.

A. Shenoy, E. Butterworth, and E. H. Huang, ALDH as a marker for enriching tumorigenic human colonic stem cells, Methods in molecular biology, vol.916, pp.373-385, 2012.

C. Alix-panabieres and K. Pantel, Challenges in circulating tumour cell research, Nature reviews. Cancer, vol.14, pp.623-631, 2014.

M. Yu, Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility, Science, vol.345, pp.216-220, 2014.

I. Baccelli, Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay, Nature biotechnology, vol.31, pp.539-544, 2013.

C. L. Hodgkinson, Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer, Nature medicine, vol.20, pp.897-903, 2014.

E. Deneve, Capture of viable circulating tumor cells in the liver of colorectal cancer patients, Clinical chemistry, vol.59, pp.1384-1392, 2013.

P. Larki, Coexistence of KRAS and BRAF Mutations in Colorectal Cancer: A Case Report Supporting The Concept of Tumoral Heterogeneity, Cell journal, vol.19, pp.113-117, 2017.

S. T. Ligthart, Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer, PloS one, vol.8, 2013.

Y. Hong, F. Fang, and Q. Zhang, Circulating tumor cell clusters: What we know and what we expect (Review), International journal of oncology, vol.49, pp.2206-2216, 2016.

C. Alix-panabières, S. Mader, and K. Pantel, Epithelial-mesenchymal plasticity in circulating tumor cells, Journal of Molecular Medicine, vol.95, pp.133-142, 2017.

X. Zhang, Inhibition of FOXQ1 induces apoptosis and suppresses proliferation in prostate cancer cells by controlling BCL11A/ MDM2 expression, Oncol Rep, vol.36, pp.2349-2356, 2016.

R. Scientific, , vol.8, 2018.

S. Assou, A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas, Stem Cells, vol.25, pp.961-973, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00128925

S. A. Mani, The epithelial-mesenchymal transition generates cells with properties of stem cells, Cell, vol.133, pp.704-715, 2008.

M. Mazel, Frequent expression of PD-L1 on circulating breast cancer cells, Molecular oncology, vol.9, pp.1773-1782, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01162382

R. A. Droeser, Clinical impact of programmed cell death ligand 1 expression in colorectal cancer, Eur J Cancer, vol.49, pp.2233-2242, 2013.

H. B. Wang, Rise of PD-L1 expression during metastasis of colorectal cancer: Implications for immunotherapy, J Dig Dis, vol.18, pp.574-581, 2017.

M. Albitar, Expression of PD-L1 in colorectal cancer that lack mutations in RAS or TP53 genes, Journal of Clinical Oncology, vol.35, pp.14500-14500, 2017.

M. Dankner, S. D. Gray-owen, Y. H. Huang, R. S. Blumberg, and N. Beauchemin, CEACAM1 as a multi-purpose target for cancer immunotherapy, Oncoimmunology, vol.6, 2017.

X. Zeng, Clinical Significance of Serum Interleukin-31 and Interleukin-33 Levels in Patients of Endometrial Cancer: A Case Control Study, Dis Markers, vol.9262919, 2016.

R. Loria, Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells, Oncotarget, vol.6, pp.2779-2793, 2015.

K. Bartkowiak, Disseminated Tumor Cells Persist in the Bone Marrow of Breast Cancer Patients through Sustained Activation of the Unfolded Protein Response, Cancer research, vol.75, pp.5367-5377, 2015.

D. Fumagalli, A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes, BMC Cancer, vol.10, 2010.

C. Alix-panabieres, Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer, Breast cancer research: BCR, vol.11, 2009.

A. Soler, L. Cayrefourcq, M. Mazel, and C. Alix-panabieres, EpCAM-Independent Enrichment and Detection of Viable Circulating Tumor Cells Using the EPISPOT Assay, Methods in molecular biology, vol.1634, pp.263-276, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01755569